CNS Pharmaceuticals director Michal Fisher acquires $10,000 of common shares
CNSP•Director purchases common shares
CNS Pharmaceuticals director Michal Fisher bought 2,000 common shares at USD 5 per share.
Direct holding rose to 2,000 shares following the purchase.
Related News
Chime Financial Inc <CHYM.O>: Morgan Stanley raises target price to $39.00 from $33.00
CHYM•
Marriott Vacations’ SVP, Corporate Controller and Chief Accounting Officer Kathleen A. Pighini disposes of 2,500 common shares for $300,000
VAC•
Acuity names Siemens executive Ruth Gratzke president of Acuity Brands Lighting
AYI•
